Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tcelna® (imilecleucel-T)
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide)
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
New multiple sclerosis phenotypic classification.
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
Glatiramer acetate ameliorates experimental autoimmune neuritis.
The interplay between the intestinal microbiota and the brain.
ARESTIN®
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
[The membrane stabilizing effect of glatiramer acetate in multiple sclerosis].
Merck: Regulatory Update on Cladribine Tablets
The role of T cell apoptosis in nervous system autoimmunity.
EMD Serono
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.
Alemtuzumab
Rituximab, an anti-CD20 monoclonal antibody: History & mechanism: Off label rituximab use in transplant patients
More to come: humoral immune responses in MS.
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
Tecfidera(®): an approach for repurposing.
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Effects of an aqueous extract of North American ginseng on MOG((35-55))-induced EAE in mice.
B cells and multiple sclerosis.
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »
